🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Have you read DoubleBlind issue 12 yet? Here's a preview: instagram.com/p/DHbOLC9R6HS

Psychedelic healing has always been communal, yet Western retreats sell it as personal optimization. If healing dissolves the ego, why market it around self-transformation? We unpack this paradox in our latest premium feature: newsletter.doubleblindmag.com/p/why-psychede…

Psilocybin sugar cubes, DMT vapes, and coca tea — served up in a spot that’s rewriting the rules of prohibition. Vancouver’s underground scene is wilder than you think 🍄👀 newsletter.doubleblindmag.com/p/psilocybin-s…

In today’s Drop In: what the latest science says about LSD for ADHD, new research on how ayahuasca enhances memory, and stories on nexus flipping, MDMA + parenting, and city-grown mushrooms. Plus, details on our upcoming LSD synthesis workshop. newsletter.doubleblindmag.com/p/will-microdo…

What happens when you spend 5 days in total darkness—no phone, no light, no psychedelics? For some, it’s like tripping without drugs. For others, it’s a return to ancestral memory. Our latest, by Mattha Busby newsletter.doubleblindmag.com/p/when-the-abs…

Catastrophic floods have submerged Shipibo-Konibo villages in the Amazon—and ancestral healers are calling for help. Plus: a brain-boosting designer stimulant, kanna, sass, and three kinds of ketamine. newsletter.doubleblindmag.com/p/here-s-what-…

The world’s most iconic mushroom is now under federal scrutiny. Amanita muscaria is being tied to hospitalizations—but is it really the culprit, or just the scapegoat? Webb Wright reports: newsletter.doubleblindmag.com/p/amanita-musc…

Today's Drop In covers two big ones: the psilocybin spore crackdown and how your gut might shape your trip. Plus: Alice Coltrane, the orange juice myth, and psychedelics’ dance with death. newsletter.doubleblindmag.com/p/spore-bans-a…

Sasha Shulgin created over 500 psychedelic compounds. Now, a research institute is digging through his archive—searching for forgotten molecules that could shape the future of psychedelic medicine. newsletter.doubleblindmag.com/p/what-happens…

They’re tiny, iconic, and sometimes downright mystical. We talked to counterculture scholar Erik Davis about the LSD blotters that defined an era—and the stories behind them will melt your face. newsletter.doubleblindmag.com/p/the-most-ico…

In the hills above Montego Bay, a Rastafari community is hosting mushroom retreats — not to mimic Western trends, but to sustain their way of life and preserve a culture long pushed to the margins. Our latest FriYAY feature: newsletter.doubleblindmag.com/p/how-a-rasta-…

Can raving save your mind? One therapist says yes—absolutely. A new study links dancing to lower depression, and now therapists are eyeing dance floors as sites for healing, connection, and transformation. newsletter.doubleblindmag.com/p/raving-is-ha…

Some say psychedelics require therapy. Others say the medicine works on its own. As the FDA inches closer to approving treatments, the debate isn’t just philosophical—it’s personal and political. @Matthabusby with our latest Wednesday Dispatch. newsletter.doubleblindmag.com/p/do-psychedel…

Long before they hit secret menus and WhatsApp threads, mushrooms and cacao were sacred medicine. Now chocohongos are everywhere in México. Is this the return of ritual—or something else? newsletter.doubleblindmag.com/p/what-chocoho…

The Drop In is live! We cover New Mexico’s new psilocybin law, the lore of Pink Buffalo mushrooms, zebrafish on ayahuasca, and Pablo Amaringo’s art. Plus: a wild preview on the dark side of ketamine. newsletter.doubleblindmag.com/p/new-mexico-l…

You’re mid-trip, vibing, then someone passes the joint. Do you take a hit…or nah? Mixing weed with psychedelics is common, but is it wise? We dug into the weird, the wonderful, and the risky. newsletter.doubleblindmag.com/p/acid-weed-mu…

It can lift depression in hours when nothing else works. But as ketamine use skyrockets—from clinics to mail-order injectables—some experts warn: this is starting to look like the opioid crisis. newsletter.doubleblindmag.com/p/is-ketamine-…

Changa isn’t so traditional. Popularized in the early 2000s by Australian Julian Palmer, it’s a smokable blend of caapi vine and DMT. Palmer coined the name, but people had been mixing DMT with herbs long before. What’s your experience with it? newsletter.doubleblindmag.com/p/what-to-know…

In the back of an ambulance, a patient gets a shot of ketamine to quell the pain. Moments later, they slip into a world that feels alien, transcendent, and completely out of body. How often is this happening, and are doctors prepared to guide them? newsletter.doubleblindmag.com/p/are-patients…

The new Drop In is live: A coca research project w/ a new approach to studying plant medicine, psychedelics for chronic illness, what’s lost when we strip psilocybin from the mushroom, and a guide to LSA. newsletter.doubleblindmag.com/p/is-coca-the-…